Drug Safety

Title Publication Date Language Citations
Use of Measures of Disproportionality in Pharmacovigilance2002/01/01English117
Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?2018/03/02English117
Drug-Related Problems in Hospitalised Patients2000/01/01English116
Complications of Regional Anaesthesia2001/01/01English116
Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art2014/08/24English115
Adverse Drug Reaction Reporting by Patients in the Netherlands2008/01/01English115
The Impact of Unlicensed and Off-Label Drug Use on Adverse Drug Reactions in Paediatric Patients2004/01/01English114
Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies2017/06/05English114
Side Effects of Cytokines Approved for Therapy2014/10/01English113
Antidepressant Discontinuation Syndromes2001/01/01English113
Benefits and Risks of Using Smart Pumps to Reduce Medication Error Rates: A Systematic Review2014/10/08English113
Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children2002/01/01English112
Bodyweight Gain and Anticonvulsants2001/01/01English112
Comparative Tolerability of the HMG-CoA Reductase Inhibitors2000/01/01English111
The Serotonin Syndrome1995/08/01English111
Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)2013/04/26English111
Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBaseā„¢2010/06/01English110
Adverse Effects of Systemic Opioid Analgesics1992/01/01English110
Post-Transplant Diabetes Mellitus The Role of Immunosuppression1997/04/01English110
Topical Nonsteroidal Anti-Inflammatory Drugs for Ophthalmic Use2002/01/01English109
New Drugs for Insomnia2003/01/01English108
Pharmacovigilance Activities in 55 Low- and Middle-Income Countries2010/08/01English107
Incidence and Costs of Adverse Drug Reactions During Hospitalisation2000/01/01English107
Safety Profile of the Fluoroquinolones2010/05/01English106
Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors2017/12/02English106
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis2016/06/09English106
Comparative Tolerability of Drug Therapies for Hypercalcaemia of Malignancy1999/01/01English106
Quantitative Methods in Pharmacovigilance2003/01/01English106
Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicators of Efficacy2013/04/26English106
Drug-Induced Diarrhoea2000/01/01English105